Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.
Copaescu AM, Vogrin S, James F, Chua KYL, Rose MT, De Luca J, Waldron J, Awad A, Godsell J, Mitri E, Lambros B, Douglas A, Youcef Khoudja R, Isabwe GAC, Genest G, Fein M, Radojicic C, Collier A, Lugar P, Stone C, Ben-Shoshan M, Turner NA, Holmes NE, Phillips EJ, Trubiano JA. Copaescu AM, et al. Among authors: james f. JAMA Intern Med. 2023 Sep 1;183(9):944-952. doi: 10.1001/jamainternmed.2023.2986. JAMA Intern Med. 2023. PMID: 37459086 Clinical Trial.
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.
Copaescu A, Mouhtouris E, Vogrin S, James F, Chua KYL, Holmes NE, Douglas A, Slavin MA, Cleland H, Zubrinich C, Aung AK, Goh MSY, Phillips EJ, Trubiano JA; Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR). Copaescu A, et al. Among authors: james f. J Allergy Clin Immunol Pract. 2021 May;9(5):2010-2015.e4. doi: 10.1016/j.jaip.2020.12.052. Epub 2021 Jan 13. J Allergy Clin Immunol Pract. 2021. PMID: 33453452
Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets.
Drewett GP, Copaescu A, Mouhtouris E, Hannan N, James F, Smibert O, Holmes NE, Trubiano JA. Drewett GP, et al. Among authors: james f. J Clin Immunol. 2021 Aug;41(6):1162-1164. doi: 10.1007/s10875-021-01039-x. Epub 2021 Apr 16. J Clin Immunol. 2021. PMID: 33864183 Free PMC article. No abstract available.
Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study.
Muhi S, Tayler N, Hoang T, Ballard SA, Graham M, Rojek A, Kwong JC, Trubiano JA, Smibert O, Drewett G, James F, Gardiner E, Chea S, Isles N, Sait M, Pasricha S, Taiaroa G, McAuley J, Williams E, Gibney KB, Stinear TP, Bond K, Lewin SR, Putland M, Howden BP, Williamson DA. Muhi S, et al. Among authors: james f. Lancet Reg Health West Pac. 2021 Apr;9:100115. doi: 10.1016/j.lanwpc.2021.100115. Epub 2021 Mar 2. Lancet Reg Health West Pac. 2021. PMID: 33937887 Free PMC article.
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.
Nguyen THO, Rowntree LC, Petersen J, Chua BY, Hensen L, Kedzierski L, van de Sandt CE, Chaurasia P, Tan HX, Habel JR, Zhang W, Allen LF, Earnest L, Mak KY, Juno JA, Wragg K, Mordant FL, Amanat F, Krammer F, Mifsud NA, Doolan DL, Flanagan KL, Sonda S, Kaur J, Wakim LM, Westall GP, James F, Mouhtouris E, Gordon CL, Holmes NE, Smibert OC, Trubiano JA, Cheng AC, Harcourt P, Clifton P, Crawford JC, Thomas PG, Wheatley AK, Kent SJ, Rossjohn J, Torresi J, Kedzierska K. Nguyen THO, et al. Among authors: james f. Immunity. 2021 May 11;54(5):1066-1082.e5. doi: 10.1016/j.immuni.2021.04.009. Epub 2021 Apr 15. Immunity. 2021. PMID: 33951417 Free PMC article.
Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity.
Zhang W, Chua B, Selva K, Kedzierski L, Ashhurst T, Haycroft E, Shoffner S, Hensen L, Boyd D, James F, Mouhtouris E, Kwong J, Chua K, Drewett G, Copaescu A, Dobson J, Rowntree L, Habel J, Allen L, Koay HF, Neil J, Gartner M, Lee C, Andersson P, Seemann T, Sherry N, Amanat F, Krammer F, Londrigan S, Wakim L, King N, Godfrey D, Mackay L, Thomas P, Nicholson S, Arnold K, Chung A, Holmes N, Smibert O, Trubiano J, Gordon C, Nguyen T, Kedzierska K. Zhang W, et al. Among authors: james f. Res Sq [Preprint]. 2021 Aug 26:rs.3.rs-802084. doi: 10.21203/rs.3.rs-802084/v1. Res Sq. 2021. PMID: 34462740 Free PMC article. Updated. Preprint.
Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral Replication.
Gordon CL, Smibert OC, Holmes NE, Chua KYL, Rose M, Drewett G, James F, Mouhtouris E, Nguyen THO, Zhang W, Kedzierski L, Rowntree LC, Chua BY, Caly L, Catton MG, Druce J, Sait M, Seemann T, Sherry NL, Howden BP, Kedzierska K, Kwong JC, Trubiano JA. Gordon CL, et al. Among authors: james f. Open Forum Infect Dis. 2021 Aug 2;8(9):ofab359. doi: 10.1093/ofid/ofab359. eCollection 2021 Sep. Open Forum Infect Dis. 2021. PMID: 34514016 Free PMC article.
Are NKT cells a useful predictor of COVID-19 severity?
Koay HF, Gherardin NA, Nguyen THO, Zhang W, Habel JR, Seneviratna R, James F, Holmes NE, Smibert OC, Gordon CL, Trubiano JA, Kedzierska K, Godfrey DI. Koay HF, et al. Among authors: james f. Immunity. 2022 Feb 8;55(2):185-187. doi: 10.1016/j.immuni.2022.01.005. Epub 2022 Jan 19. Immunity. 2022. PMID: 35104438 Free PMC article. No abstract available.
428 results